Amundi Pioneer Asset Management Inc. lessened its position in shares of Colgate-Palmolive (NYSE:CL) by 65.4% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,149,075 shares of the company’s stock after selling 2,170,200 shares during the quarter. Amundi Pioneer Asset Management Inc. owned approximately 0.13% of Colgate-Palmolive worth $78,757,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. Capital Financial Planning LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter valued at about $27,000. Parisi Gray Wealth Management increased its position in shares of Colgate-Palmolive by 365.3% during the fourth quarter. Parisi Gray Wealth Management now owns 470 shares of the company’s stock valued at $28,000 after acquiring an additional 369 shares during the last quarter. Meridian Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive during the first quarter valued at about $29,000. Portfolio Solutions LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter valued at about $30,000. Finally, WP Advisors LLC acquired a new stake in shares of Colgate-Palmolive during the first quarter valued at about $34,000. Institutional investors own 75.72% of the company’s stock.
In other Colgate-Palmolive news, insider Ian M. Cook sold 19,500 shares of the company’s stock in a transaction dated Monday, April 29th. The shares were sold at an average price of $71.28, for a total value of $1,389,960.00. Following the transaction, the insider now directly owns 1,091,793 shares in the company, valued at approximately $77,823,005.04. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Noel R. Wallace sold 84,351 shares of the stock in a transaction dated Wednesday, May 1st. The stock was sold at an average price of $71.89, for a total transaction of $6,063,993.39. Following the transaction, the chief executive officer now owns 279,023 shares in the company, valued at $20,058,963.47. The disclosure for this sale can be found here. Insiders sold a total of 362,184 shares of company stock worth $25,909,426 over the last three months. 1.14% of the stock is currently owned by corporate insiders.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, April 26th. The company reported $0.67 EPS for the quarter, beating the consensus estimate of $0.66 by $0.01. The business had revenue of $3.88 billion during the quarter, compared to analysts’ expectations of $3.86 billion. During the same quarter last year, the company earned $0.74 EPS. The firm’s revenue for the quarter was down 2.9% compared to the same quarter last year. As a group, analysts forecast that Colgate-Palmolive will post 2.84 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Thursday, July 18th will be paid a $0.43 dividend. The ex-dividend date of this dividend is Wednesday, July 17th. This represents a $1.72 annualized dividend and a yield of 2.37%. Colgate-Palmolive’s dividend payout ratio is currently 57.91%.
A number of brokerages recently weighed in on CL. Bank of America set a $80.00 price objective on shares of Colgate-Palmolive and gave the company a “buy” rating in a report on Friday, July 12th. Macquarie began coverage on shares of Rollins in a report on Monday, April 29th. They issued a “neutral” rating and a $38.90 price objective for the company. Wells Fargo & Co set a $29.00 price objective on shares of Establishment Labs and gave the company a “buy” rating in a report on Friday, July 12th. UBS Group lifted their price objective on shares of Colgate-Palmolive from $71.00 to $75.00 and gave the company a “buy” rating in a report on Friday, March 29th. Finally, Deutsche Bank lifted their price objective on shares of Spirit Airlines from $75.00 to $79.00 and gave the company a “buy” rating in a report on Friday, July 12th. One analyst has rated the stock with a sell rating, thirteen have issued a hold rating and six have given a buy rating to the company’s stock. Colgate-Palmolive currently has an average rating of “Hold” and a consensus target price of $71.94.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
See Also: Federal Reserve
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.